DVAX Insider Trading Activity and SEC Form 4 Filings
DVAX insider trading summary
Over the past 12 months, insiders at Dynavax Technologies Corp (DVAX) reported 1 sale worth $1.8M by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $1.8M.
Latest DVAX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 15, 2026 | David F Novack | President & COO | Sell | $1.8M (114,000 @ $15.64) |
| Aug 22, 2025 | David Kroin | Insider | Sell | $10.3M (970,143 @ $10.59) |
| Aug 22, 2025 | Deep Track Capital, LP | Insider | Sell | $10.3M (970,143 @ $10.59) |
| Aug 22, 2025 | Deep Track Biotechnology Master Fund, Ltd. | Insider | Sell | $10.3M (970,143 @ $10.59) |
| Aug 22, 2025 | Scott Dunseth Myers | Director | Buy | $41K (3,800 @ $10.82) |
| Aug 21, 2025 | Deep Track Biotechnology Master Fund, Ltd. | Insider | Sell | $12.1M (1,094,994 @ $11.03) |
| Aug 21, 2025 | David Kroin | Insider | Sell | $12.1M (1,094,994 @ $11.03) |
| Aug 21, 2025 | Deep Track Capital, LP | Insider | Sell | $12.1M (1,094,994 @ $11.03) |
| Mar 24, 2025 | David F Novack | President & COO | Sell | $140K (10,000 @ $14.00) |
| Mar 18, 2025 | David F Novack | President & COO | Sell | $190K (14,020 @ $13.58) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.